{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:23:39Z","timestamp":1786983819952,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytical Biochemistry"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.ab.2009.10.014","type":"journal-article","created":{"date-parts":[[2009,10,14]],"date-time":"2009-10-14T14:14:00Z","timestamp":1255529640000},"page":"168-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Simultaneous quantification of 8-iso-prostaglandin-F2\u03b1 and 11-dehydro thromboxane B2 in human urine by liquid chromatography\u2013tandem mass spectrometry"],"prefix":"10.1016","volume":"397","author":[{"given":"Viviana","family":"Cavalca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Minardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuele","family":"Scurati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Guidugli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Squellerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Veglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Dainese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Guarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Tremoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ab.2009.10.014_bib1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jchromb.2005.03.038","article-title":"Separation and identification of F2-isoprostane regioisomers and diastereomers by novel liquid chromatographic\/mass spectrometric methods","volume":"827","author":"Yin","year":"2005","journal-title":"J. Chromatogr. B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.ab.2009.10.014_bib2","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0165-6147(02)02053-9","article-title":"Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications","volume":"23","author":"Cracowski","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ab.2009.10.014_bib3","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1159\/000107699","article-title":"Plasma F2A isoprostane levels in Alzheimer\u2019s and Parkinson\u2019s disease","volume":"4","author":"Irizarry","year":"2007","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.ab.2009.10.014_bib4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pharmthera.2008.01.001","article-title":"Thromboxane A2: physiology\/pathophysiology, cellular signal transduction and pharmacology","volume":"118","author":"Nakahata","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ab.2009.10.014_bib5","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1089\/ars.2007.1956","article-title":"F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications","volume":"10","author":"Basu","year":"2008","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ab.2009.10.014_bib6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1054\/plef.1999.0113","article-title":"Vascular effects of isoprostanes after endothelial damage","volume":"61","author":"Sametz","year":"1999","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.ab.2009.10.014_bib7","doi-asserted-by":"crossref","first-page":"895","DOI":"10.2174\/138161206776055985","article-title":"The isoprostanes\u2014unique products of arachidonate peroxidation: their role as mediators of oxidant stress","volume":"12","author":"Morrow","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ab.2009.10.014_bib8","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/j.1538-7836.2004.00836.x","article-title":"Platelet activation in type 2 diabetes mellitus","volume":"2","author":"Ferroni","year":"2004","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ab.2009.10.014_bib9","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1161\/01.ATV.17.11.2309","article-title":"Isoprostanes: potential markers of oxidant stress in atherothrombotic disease","volume":"17","author":"Patrono","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ab.2009.10.014_bib10","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1161\/01.CIR.101.24.2833","article-title":"Cardiovascular responses to the isoprostanes iPF(2alpha)-III and iPE(2)-III are mediated via the thromboxane A(2) receptor in vivo","volume":"101","author":"Audoly","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ab.2009.10.014_bib11","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.bcp.2008.03.014","article-title":"Characterization of isoprostane signaling: evidence for a unique coordination profile of 8-iso-PGF(2alpha) with the thromboxane A(2) receptor, and activation of a separate cAMP-dependent inhibitory pathway in human platelets","volume":"75","author":"Khasawneh","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ab.2009.10.014_bib12","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.tips.2005.10.001","article-title":"Thromboxane, prostacyclin and isoprostanes: therapeutic targets in atherogenesis","volume":"26","author":"Dogne","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"issue":"Suppl.","key":"10.1016\/j.ab.2009.10.014_bib13","first-page":"57","article-title":"Lipid peroxidation, isoprostanes and vascular damage","volume":"58","author":"Minuz","year":"2006","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ab.2009.10.014_bib14","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/01.CIR.99.2.224","article-title":"In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation","volume":"99","author":"Davi","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ab.2009.10.014_bib15","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/hc3501.095287","article-title":"Oxidative stress and platelet activation in homozygous homocystinuria","volume":"104","author":"Davi","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ab.2009.10.014_bib16","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.288.16.2008","article-title":"Platelet activation in obese women: role of inflammation and oxidant stress","volume":"288","author":"Davi","year":"2002","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ab.2009.10.014_bib17","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.freeradbiomed.2009.01.005","article-title":"Determinants of platelet activation in hypertensives with microalbuminuria","volume":"46","author":"Guagnano","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ab.2009.10.014_bib18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.prostaglandins.2004.01.003","article-title":"Quantitative liquid chromatography\u2013tandem mass spectrometric analysis of 11-dehydro TXB2 in urine","volume":"73","author":"Suzuki","year":"2004","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.ab.2009.10.014_bib19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ab.2005.12.003","article-title":"Benefits of prolonged gradient separation for high-performance liquid chromatography\u2013tandem mass spectrometry quantitation of plasma total 15-series F-isoprostanes","volume":"350","author":"Taylor","year":"2006","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ab.2009.10.014_bib20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1054\/plef.2002.0381","article-title":"Simultaneous quantification of prostaglandins in human synovial cell-cultured medium using liquid chromatography\/tandem mass spectrometry","volume":"67","author":"Takabatake","year":"2002","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.ab.2009.10.014_bib21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1373\/clinchem.2006.074989","article-title":"Isoprostane measurement in plasma and urine by liquid chromatography\u2013mass spectrometry with one-step sample preparation","volume":"53","author":"Sircar","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ab.2009.10.014_bib22","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1194\/jlr.M700097-JLR200","article-title":"Quantitation of isoprostane isomers in human urine from smokers and nonsmokers by LC\u2013MS\/MS","volume":"48","author":"Yan","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ab.2009.10.014_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0098-2997(02)00017-1","article-title":"Biomarkers","volume":"23","author":"Griffiths","year":"2002","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.ab.2009.10.014_bib24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nprot.2006.375","article-title":"Quantification of F2-isoprostanes as a biomarker of oxidative stress","volume":"2","author":"Milne","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ab.2009.10.014_bib25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1572-0241.2002.05427.x","article-title":"Increased urinary F2-isoprostanes in patients with Crohn\u2019s disease","volume":"97","author":"Cracowski","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.ab.2009.10.014_bib26","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0891-5849(95)02087-X","article-title":"Measurement of urinary 8-Epi-prostaglandin F2alpha, a novel index of lipid peroxidation in vivo, by immunoaffinity extraction\/gas chromatography\u2013mass spectrometry. Basal levels in smokers and nonsmokers","volume":"20","author":"Bachi","year":"1996","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ab.2009.10.014_bib27","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90380-0","article-title":"Tandem mass spectrometric determination of 11-dehydrothromboxane B2, an index metabolite of thromboxane B2 in plasma and urine","volume":"164","author":"Schweer","year":"1987","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ab.2009.10.014_bib28","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0378-4347(93)80161-V","article-title":"Improved assay for the quantification of 11-dehydrothromboxane B2 by gas chromatography\u2013mass spectrometry","volume":"612","author":"Morrow","year":"1993","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.ab.2009.10.014_bib29","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.clinbiochem.2007.07.023","article-title":"Quantification of urinary 8-iso-PGF2alpha using liquid chromatography\u2013tandem mass spectrometry and association with elevated troponin levels","volume":"40","author":"Saenger","year":"2007","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ab.2009.10.014_bib30","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.freeradbiomed.2006.09.001","article-title":"Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery disease","volume":"41","author":"Shishehbor","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ab.2009.10.014_bib31","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.athoracsur.2005.08.019","article-title":"Isoprostanes and oxidative stress in off-pump and on-pump coronary bypass surgery","volume":"81","author":"Cavalca","year":"2006","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.ab.2009.10.014_bib32","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1161\/CIRCULATIONAHA105.562223","article-title":"Involvement of thromboxane receptor in the proatherogenic effect of isoprostane F2alpha-III: evidence from apolipoprotein E- and LDL receptor-deficient mice","volume":"112","author":"Tang","year":"2005","journal-title":"Circulation"}],"container-title":["Analytical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269709007143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269709007143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T20:56:19Z","timestamp":1757710579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003269709007143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0003269709007143"],"URL":"https:\/\/doi.org\/10.1016\/j.ab.2009.10.014","relation":{},"ISSN":["0003-2697"],"issn-type":[{"value":"0003-2697","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simultaneous quantification of 8-iso-prostaglandin-F2\u03b1 and 11-dehydro thromboxane B2 in human urine by liquid chromatography\u2013tandem mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Analytical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ab.2009.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}